BTMPS has been detected in all regions across the United States, demonstrating vast prevalence. BTMPS has appeared in more than 600 drug materials tested by our laboratory. Tetramethyl-4-piperidinol (TMP) was first detected in August 2024 and since has appeared in more than 20 drug materials. Tetramethyl-4-AP (TM-4-AP) and tetramethylnorfentanyl (TMNF) were first detected in April 2025 and since have appeared in more than ten drug materials, often together. To date, a substance suspected of being tetramethylfentanyl (TMF) has been identified in only small (or trace) amounts alongside these other related substances; however, confirmation of this substance is pending acquisition of standard reference material.
(Publisher abstract provided.)
Downloads
Similar Publications
- Data fusion from infrared, elemental, MSP and Raman for maximizing the efficiency of the forensic examination of paint evidence
- Ultrahigh Speed Direct PCR: A Method for Obtaining Y-STR and STR Based Genotypes in Under 20 Minutes
- Application of the Optimized Summed Score Attributes Method for Sex Estimation